Use of capecitabine in management of early colon cancer

References

• GrayRFBrewsterDHKiddJBurnsHColorectal cancer in Scotland: recent trends in incidence and mortalityGastrointest Oncol.20024213222
   Google Scholar
• HayneDBrownRMcCormackMCurrent trends in colorectal cancer: site, incidence, mortality and survival in England and WalesClin Oncol.200113448452
   Web of Science ®Google Scholar
• Office for National StatisticsCancer statistics – registrations, England, 2006. Series MB1 no. 37London, UKOffice for National Statistics2008
   Google Scholar
• National Cancer Intelligence NetworkColorectal cancer survival by stage – NCIN Data Briefing20096 Available from: http://www.ncin.org.uk/publications/data_briefings/colorectal_cancer_survival_by_stage.aspxAccessed August 1, 2011
   Google Scholar
• DukesCEThe classification of cancer of the rectumJ Pathol.193235323332
   Google Scholar
• BeahrsOHHensonDEHutterDEManual for Staging of Cancer3rd edPhiladelphiaLippincott1988
   Google Scholar
• EdgeSBByrdDRComptonCCAJCC (American Joint Committee on Cancer) Cancer Staging Manual7th edSpringerNew York2010143
   Google Scholar
• QUASAR Collaborative GroupComparison of fluorouracil with additional levamisole, higher dose folinic acid or both as adjuvant chemotherapy for colorectal cancer: a randomised trialLancet.20003551588159610821362
   PubMed Web of Science ®Google Scholar
• HeidelbergerCChaudhuriNKDannebergPFluorinated pyrimidines, a new class of tumour-inhibitory compoundsNature.195717966366613418758
   PubMed Web of Science ®Google Scholar
• Modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rateAdvanced Colorectal Cancer Meta-Analysis ProjectJ Clin Oncol.1992108969031534121
   PubMed Web of Science ®Google Scholar
• MoertelCGFlemingTRMacdonaldJSLevamisole and fluorouracil for adjuvant therapy of resected colon carcinomaN Engl J Med.19903223523582300087
   PubMed Web of Science ®Google Scholar
• International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) InvestigatorsEfficacy of adjuvant fluorouracil and folinic acid in colon cancerLancet19953459399447715291
   PubMed Web of Science ®Google Scholar
• CarratoAKohneCBedenneLFolinic acid modulated bolus 5-FU or infusional 5-FU treatment of patients of UICC stage III colon cancer: preliminary analysis of the PETACC-2-studyProc ASCO.20062418 Suppl161s
   Google Scholar
• GoldbergROxaliplatin in colorectal cancer: current studiesOncology (Williston Park).20001412 Suppl 11424711204663
   PubMed Web of Science ®Google Scholar
• SchmollHJCassidyJIntegrating oxaliplatin into the management of colorectal cancerOncologist.20016Suppl 4242811585971
   PubMed Web of Science ®Google Scholar
• AndréTBoniCMounedji-BoudiafLfor the Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) InvestigatorsOxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancerN Engl J Med.20043502343235115175436
   PubMed Web of Science ®Google Scholar
• FraileRJBakerLHBurokerTRPharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusionCancer Res.198040222322287388790
   PubMed Web of Science ®Google Scholar
• MilanoGSchellensJHMPyrimidine antimetabolitesSchellensJHMMcLeodHLNewellDRCancer Clinical PharmacologyOxfordUniversity Press20055162
   Google Scholar
• XuYGremJLLiquid chromatography-mass spectrometry method for the analysis of the anti-cancer agent capecitabine and its nucleoside metabolites in human plasmaJ Chromatogr B Biomed Appl.2003783273285
   PubMed Web of Science ®Google Scholar
• TwelvesCGlynne-JonesRCassidyJEffect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolitesClin Cancer Res.199849419489563888
   PubMed Web of Science ®Google Scholar
• CassidyJDouillardJYTwelvesCPharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes’ C colon cancer: the X-ACT trialBr J Cancer.2006941122112916622438
   PubMed Web of Science ®Google Scholar
• Van CutsemEHoffPHarperPOral capecitabine versus intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trialsBr J Cancer.2004901190119715026800
   PubMed Web of Science ®Google Scholar
• SchmollHJCartwrightTTaberneroJPhase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patientsJ Clin Oncol.20072510210917194911
   PubMed Web of Science ®Google Scholar
• AlbertsSRSargentDJSmyrkTCAdjuvant mFOLFOX6 with or without cetuximab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): results from NCCTG Intergroup Phase III Trial N0147J Clin Oncol.201028Suppl abstr CRA3507262s
   Google Scholar
• RocheRoche provides results on Avastin in adjuvant colon cancer [Press release 2010 Sep 18]RocheBasel, Switzerland
   Google Scholar
• AllegraCJYothersGO’ConnellMJPhase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08J Clin Oncol.201129111620940184
   PubMed Web of Science ®Google Scholar
• TwelvesCBoyerMFindlayMCapecitabine (Xeloda™) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinomaEur J Cancer.20013759760411290435
   PubMed Web of Science ®Google Scholar
• RibicCMSargentDJMooreMJTumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancerN Engl J Med.200334924725712867608
   PubMed Web of Science ®Google Scholar
• KimGPColangeloLHWieandHSPrognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project collaborative studyJ Clin Oncol.20072576777217228023
   PubMed Web of Science ®Google Scholar
• Van CutsemELabiancaRBodokyGRandomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3J Clin Oncol273117312519451425
   PubMed Web of Science ®Google Scholar